Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLXDC2 antisense RNA 1 (PLXDC2-AS1)
- Target
- PLXDC2-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
PLXDC2 antisense RNA 1 (PLXDC2-AS1) is a long non-coding antisense RNA located opposite the PLXDC2 gene locus. Antisense RNAs in general regulate gene expression through mechanisms such as transcriptional interference and modulation of chromatin state, but there are currently no publications specifically describing the function, biological role, disease relevance, or clinical importance of PLXDC2-AS1 in humans.\n\nImportant distinction: PLXDC2-AS1 is not the same as the PLXDC2 protein, which is a validated cell-surface receptor and has roles in PEDF signaling, cancer, and vascular biology. PLXDC2-AS1 is a non-coding RNA with little or no data linking it to clinical targeting or drug development.
- Other names
- PLXDC2-AS1PLXDC2 antisense RNA 1
02
Mechanism of action
None established. General mechanisms for antisense RNAs include transcriptional interference, modulation of sense transcript levels, and chromatin remodeling, but no drug mechanism is described for this lncRNA.
03
Biological functions
Epigenetic and transcriptional regulation (general for antisense lncRNAs)Other (Specific biological function of PLXDC2-AS1 remains unknown in current literature.)
04
Disease associations
Other (No direct disease role described for PLXDC2-AS1; most known roles pertain to protein-coding PLXDC2.)
Beyond the preview
Go deeper on PLXDC2 antisense RNA 1 (PLXDC2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PLXDC2 antisense RNA 1 (PLXDC2-AS1).